ARROWHEAD PHARMACEUTICALS: NMPA APPROVAL TRIGGERS $10 MLN MILESTONE PAYMENT TO BE PAID BY SANOFI TO ARROWHEAD SUBSIDIARY VISIRNA THERAPEUTICS

Reuters · 5d ago

Please log in to view news